The value of pd-l1 expression as predictive biomarker in metastatic renal cell carcinoma patients: A meta-analysis of randomized clinical trials

  1. Carretero−gonzález, A.
  2. Lora, D.
  3. Sobrino, I.M.
  4. Sanz, I.S.
  5. Bourlon, M.T.
  6. Herranz, U.A.
  7. Chanzá, N.M.
  8. Castellano, D.
  9. de Velasco, G.
Revue:
Cancers

ISSN: 2072-6694

Année de publication: 2020

Volumen: 12

Número: 7

Pages: 1-16

Type: Révision

DOI: 10.3390/CANCERS12071945 GOOGLE SCHOLAR lock_openAccès ouvert editor